This surge in ROS is essential for the phosphorylation and subsequent activation of the ERK, JNK, and p38 MAPK pathways, leading to a comprehensive attack on the survival mechanisms of cancer cells (Kwak et al., 2023; Wu et al., 2022; Wang et al., 2024). The gene discussed is MAPK8; the disease is cancer.